Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fathema Uddin

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Frontiers in Oncology|August 28, 2020
CRISPR Gene Therapy: Applications, Limitations, and Implications for the FutureFathema Uddin, Charles M Rudin, Triparna Sen
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|March 7, 2018
A heterometallic ruthenium-gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancerBenelita T Elie, Yuriy Pechenyy, Fathema Uddin, et al.
Scientific Reports|July 2, 2025
Chemotherapy treatment alters DNA methylation patterns in the prefrontal cortex of female rat brainShami Chakrabarti, Chanchal Wagh, Ciara Bagnall-Moreau, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2022
Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLCEvelyn M Nguyen, Hirokazu Taniguchi, Joseph M Chan, et al.
Cell Reports|December 2, 2020
Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung CancerCorrin A Wohlhieter, Allison L Richards, Fathema Uddin, et al.
Cell Reports|May 18, 2022
WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLCHirokazu Taniguchi, Rebecca Caeser, Shweta S Chavan, et al.
Cancer Research|November 24, 2021
Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line ChemotherapyAlvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yuan Hao, et al.
Journal of Hematology & Oncology|October 17, 2021
Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiationAlvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yingqian A Zhan, et al.
Cancer Cell|October 15, 2021
Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancerJoseph M Chan, Álvaro Quintanal-Villalonga, Vianne Ran Gao, et al.
Signal Transduction and Targeted Therapy|July 25, 2024
CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradationAlvaro Quintanal-Villalonga, Kenta Kawasaki, Esther Redin, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|August 28, 2020
CRISPR Gene Therapy: Applications, Limitations, and Implications for the FutureFathema Uddin, Charles M Rudin, Triparna Sen
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|March 7, 2018
A heterometallic ruthenium-gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancerBenelita T Elie, Yuriy Pechenyy, Fathema Uddin, et al.
Scientific Reports|July 2, 2025
Chemotherapy treatment alters DNA methylation patterns in the prefrontal cortex of female rat brainShami Chakrabarti, Chanchal Wagh, Ciara Bagnall-Moreau, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2022
Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLCEvelyn M Nguyen, Hirokazu Taniguchi, Joseph M Chan, et al.
Cell Reports|December 2, 2020
Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung CancerCorrin A Wohlhieter, Allison L Richards, Fathema Uddin, et al.
Cell Reports|May 18, 2022
WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLCHirokazu Taniguchi, Rebecca Caeser, Shweta S Chavan, et al.
Cancer Research|November 24, 2021
Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line ChemotherapyAlvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yuan Hao, et al.
Journal of Hematology & Oncology|October 17, 2021
Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiationAlvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yingqian A Zhan, et al.
Cancer Cell|October 15, 2021
Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancerJoseph M Chan, Álvaro Quintanal-Villalonga, Vianne Ran Gao, et al.
Signal Transduction and Targeted Therapy|July 25, 2024
CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradationAlvaro Quintanal-Villalonga, Kenta Kawasaki, Esther Redin, et al.
Pageof 2